Peroxisome proliferator-activated receptor-γ regulates expression of PDX-1 and NKX6.1 in INS-1 cells

Diabetes

Volumn 56, Issue 1, 2007, Pages 88-95

  Moibi, Jacob A ^a   Gupta, Dhananjay ^b   Jetton, Thomas L ^b   Peshavaria, Mina ^b   Desai, Ronak ^b   Leahy, Jack L ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE TRANSPORTER 2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROINSULIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PDX 1; TROGLITAZONE; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; RNA ANALYSIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; GLUCOSE; HOMEODOMAIN PROTEINS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICROSCOPY, CONFOCAL; PANCREATECTOMY; PPAR ALPHA; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANS-ACTIVATORS;

EID: 33847065108     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0948     Document Type: Article

References (51)

1. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435-441, 1988
2. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
3. Leahy JL, Bumbalo LM, Chen C: Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats. Diabetologia 36:1238-1244, 1993
4. Liu YQ, Montanya E, Leahy JL: Increased islet DNA synthesis and glucose-derived lipid and amino acid production in association with β-cell hyperproliferation in normoglycemic 60% pancreatectomy rats. Diabetologia 44:1026-1033, 2001
5. Jetton TL, Liu YQ, Trotman WE, Nevin PW, Sun X-J, Leahy JL: Enhanced expression of insulin receptor substrate-2 and activation of protein kinase B/Akt in regenerating pancreatic duct epithelium of 60%-partial pancreatectomy rats. Diabetologia 44:2056-2065, 2001
6. Leahy JL, Bonner-Weir S, Weir GC: Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407-1414, 1988
7. Liu YQ, Nevin PW, Leahy JL: Mechanism of β-cell adaptation that preserves normoinsulinemia and normoglycemia in 60% pancreatectomy rats. Am J Physiol 279:E68-E73, 2000
8. Lehrke M, Lazar MA: The many faces of PPARgamma. Cell 123:993-999, 2005
9. Semple RK, Chatterjee VK, O'Rahilly S: PPAR gamma and human metabolic disease. J Clin Invest 116:581-589, 2006
10. Rosen ED, Spiegelman BM: Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145-171, 2000
11. Rosen ED, Spiegelman BM: PPAR-gamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734, 2001
12. de Dios ST, Bruemmer D, Dilley RJ, Ivey ME, Jennings GL, Law RE, Little PJ: Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. Circulation 107:2548-2550, 2003
13. Roth AD, Leisewitz AV, Jung JE, Cassina P, Barbeito L, Inestrosa NC, Bronfman M: PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes. J Neurosci Res 72:425-435, 2003
14. Gupta RA, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, DuBois RN: Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem 278:7431-7438, 2003
15. Frohlich E, Machicao F, Wahl R: Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture. Endocr Relat Cancer 12:291-303, 2005
16. Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu GH, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, Spiegelman BM: Targeted elimination of peroxisome proliferator-activated receptor γ in β cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol 23:7222-7229, 2003
17. Ohtani KI, Shimizu H, Sato N, Mori M: Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells. Endocrinology 139:172-178, 1998
18. Lin CY, Gurlo T, Haataja LO, Hsueh WA, Butler PC: Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 90:6678-6686, 2005
19. Servitja JM, Ferrer J: Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 47:597-613, 2004
20. Habener JF, Kemp DM, Thomas MK: Minireview: transcriptional regulation in pancreatic development. Endocrinology 146:1025-1034, 2005
21. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H: Beta-cell-specific inactivation of the mouse Ipf1/PDX1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 12:1763-1768, 1998
22. Holland AM, Hale MA, Kagami H, Hammer RE, MacDonald RJ: Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci U S A 99:12236-12241, 2002
23. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, Piston DW, Wright CV, Powers AC: Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225-11232, 2002
24. Wang H, Iezzi M, Theander S, Antinozzi PA, Gauthier BR, Halban PA, Wollheim CB: Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells. Diabetologia 48:720-731, 2005
25. Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, Polonsky KS: Increased islet apoptosis in PDX1+/- mice. J Clin Invest 111:1147-1160, 2003
26. Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Dela Cruz F, Schwitzgebel V, Hayes-Jordan A, German M: Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127:5533-5540, 2000
27. Schisler JC, Jensen PB, Taylor DG, Becker TC, Knop FK, Takekawa S, German M, Weir GC, Lu D, Mirmira RG, Newgard CB: The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc Natl Acad Sci U S A 102:7297-7302, 2005
28. Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR: PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114:828-836, 2004
29. Brissova M, Blaha M, Spear C, Nicholson W, Radhika A, Shiota M, Charron MJ, Wright CV, Powers AC: Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am J Physiol Endocrinol Metab 288:E707-E714, 2005
30. Prentki M, Joly E, El-Assaad W, Roduit R: Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 51 (Suppl. 3):S405-S413, 2002
31. Yaney GC, Corkey BE: Fatty acid metabolism and insulin secretion in pancreatic beta-cells. Diabetologia 46:1297-1312, 2003
32. Dubois M, Pattou F, Kerr-Conte J, Gmyr V, Vandewalle B, Desreumaux P, Auwerx J, Schoonjans K, Lefebvre J: Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in normal human pancreatic islet cells. Diabetologia 43:1165-1169, 2000
33. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137:354-366, 1996
34. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803, 2002
35. Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Kawakubo M, Buchanan TA: Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55:517-522, 2006
36. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR, the DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096-1105, 2006
37. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE: β-Cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death. Diabetes 50:1021-1029, 2000
38. Gupta D, Peshavaria M, Jetton JL, Desai R, Leahy JL: Transcriptional regulation of PDX-1 by PPAR-γ in islet β-cells (Abstract). Diabetes 55 (Suppl. 1):A366, 2006
39. Kim HI, Kim JW, Kim SH, Cha JY, Kim KS, Ahn YH: Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 49:1517-1524, 2000
40. Kim HI, Cha JY, Kim SY, Kim JW, Roh KJ, Seong JK, Lee NT, Choi KY, Kim KS, Ahn YH: Peroxisomal proliferator-activated receptor-γ upregulates glucokinase gene expression in β-cells. Diabetes 51:676-685, 2002
41. Sporn MB, Suh N, Mangelsdorf DJ: Prospects for prevention and treatment of cancer with selective PPAR-gamma modulators (SPARMs). Trends Mol Med 7:395-400, 2001
42. Grommes C, Landreth GE, Heneka MT: Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 5:419-429, 2004
43. Patanè G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM: Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition. Diabetes 51:2749-2756, 2002
44. Nakamichi Y, Kikuta T, Ito E, Ohara-Imaizumi M, Nishiwaki C, Ishida H, Nagamatsu S: PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells. Biochem Biophys Res Commun 306:832-836, 20003
45. Parton LE, Diraison F, Neill SE, Ghosh SK, Rubino MA, Bisi JE, Briscoe CP, Rutter GA: Impact of PPARgamma overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays. Am J Physiol Endocrinol Metab 287:E390-E404, 2004
46. Ito E, Ozawa S, Takahashi K, Tanaka T, Katsuta H, Yamaguchi S, Maruyama M, Takizawa M, Katahira H, Yoshimoto K, Nagamatsu S, Ishida H: PPAR-gamma overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein. Biochem Biophys Res Commun 324:810-814, 2004
47. Ravnskjaer K, Boergesen M, Rubi B, Larsen JK, Nielsen T, Fridriksson J, Maechler P, Mandrup S: PPARα potentiates whereas PPARγ attenuates glucose-stimulated insulin secretion in pancreatic β-cells. Endocrinology 146:3266-3276, 2005
48. Sreenan S, Sturis J, Pugh W, Burant CF, Polonsky KS: Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol 271:E742-E747, 1996
49. Shimabukuro M, Zhou YT, Lee Y, Unger RH: Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547-3550, 1998
50. Yang C, Chang TJ, Chang JC, Liu MW, Tai TY, Hsu HW, Chuang LM: Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol-3-kinase pathway. Diabetes 50:2598-2602, 2001
51. Santini E, Fallahi P, Ferrari SM, Masoni A, Antonelli A, Ferrannini E: Effect of PPAR-γ activation and inhibition on glucose-stimulated insulin release in INS-1e cells. Diabetes 53 (Suppl. 3):S79-S83, 2004